Diligence memo · auto-generated · as of July 2, 2026
Phoreus Biotechnology, Inc.
Phoreus Biotechnology, Inc. looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Phoreus Biotechnology, Inc. operates in Biotechnology, based in OLATHE.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Phoreus Biotechnology, Inc. has raised $5.4M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $4.4M on 2020-07-20.
Most recent recorded round closed around 2025-11-05.
Valuation (modeled)modeled
Provath models Phoreus Biotechnology, Inc. at approximately $1.2M (range $459K–$1.8M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.07× the median modeled value of Series A Biotechnology companies in 2025–2027 (157 peers) — value vs value, same stage and era. Issuer reports $0–$1M revenue while modeled below niche peers.
Financing rhythm & timingmixed
Historic cadence: a new round about every 17 months.
Last raise 8 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 4.6× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 46% of Biotechnology peers (4293 compared).
Modeled value ranks above 3% of those peers.
Closest niche peers: Acasti Pharma Inc., Edesa Biotech, Inc., 4DMedical Ltd, Arialys Therapeutics, Inc., Nuclein, LLC.
Peoplefiled
14 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.